ROCKVILLE, Md., June 17, 2020 /PRNewswire/ -- Emmes today announced that it was selected as one of the best places to…
Super UserJune 21, 2020
Royalty Pharma, a business built on investing in other people’s medicines, raised $2.2 billion in a record IPO on Tuesday,…
Super UserJune 21, 2020
Developing and Manufacturing Novel RNAi drug Candidates Using Precision NanoSystems' NxGen™ Platform GAITHERSBURG, MD and VANCOUVER, BC, June 17, 2020 /PRNewswire/…
Super UserJune 20, 2020
ROCKVILLE, Md. and FARMINGTON HILLS, Mich., June 17, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NasdaqCM: REXN) and Ocuphire Pharma,…
Super UserJune 20, 2020
Emergent BioSolutions (NYSE:EBS) will invest $75M in its Canton, Massachusetts facility, focused on the development and manufacturing of drug substance…
Super UserJune 20, 2020
Business is booming for Emergent BioSolutions as it has assisted in the country’s push to create COVID-19 treatments and vaccines.…
Super UserJune 20, 2020
Emergent BioSolutions has unveiled plans to strengthen its contract development and manufacturing (CDMO) capabilities by expanding into viral vector and…
Super UserJune 20, 2020
Lockheed Martin Ventures -- the defense company’s technology startup investment arm -- has backed two companies through separate avenues announced…
Super UserJune 20, 2020
BALTIMORE, June 11, 2020 (GLOBE NEWSWIRE) -- Glyscend Therapeutics, a privately held biopharmaceutical company developing novel treatments for type 2…
Super UserJune 15, 2020